These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 32390041)

  • 21. Implementation of a marker substance for monitoring in situ 17-keto modifications in endogenous steroids caused by microbiological contamination.
    Pfeffer S; Gmeiner G; Gärtner P
    Drug Test Anal; 2022 Nov; 14(11-12):1871-1876. PubMed ID: 35128824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Indomethacin on Steroid Metabolism: Endocrine Disruption and Confounding Effects in Urinary Steroid Profiling of Anti-Doping Analyses.
    Stoll A; Iannone M; De Gregorio G; Molaioni F; de la Torre X; Botrè F; Parr MK
    Metabolites; 2020 Nov; 10(11):. PubMed ID: 33202527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 7-keto-DHEAmetabolism in humans. Pitfalls in interpreting the analytical results in the antidoping field.
    Martinez-Brito D; de la Torre X; Colamonici C; Curcio D; Botrè F
    Drug Test Anal; 2019 Nov; 11(11-12):1629-1643. PubMed ID: 31701664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of Isotope Ratio Mass Spectrometry in Sports Drug Testing Accounting for Isotope Fractionation in Analysis of Biological Samples.
    Piper T; Thevis M
    Methods Enzymol; 2017; 596():403-432. PubMed ID: 28911778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Pain Killers on the Urinary Anabolic Steroid Profile.
    Stoll A; Iannone M; De Gregorio G; de la Torre X; Molaioni F; Botrè F; Kristina Parr M
    J Anal Toxicol; 2020 Dec; 44(8):871-879. PubMed ID: 32390041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complementary stable carbon isotope ratio and amount of substance measurements in sports anti-doping.
    Cawley AT; George AV
    Drug Test Anal; 2012 Dec; 4(12):897-911. PubMed ID: 22791679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing the steroid profile in doping control analysis.
    Mareck U; Geyer H; Opfermann G; Thevis M; Schänzer W
    J Mass Spectrom; 2008 Jul; 43(7):877-91. PubMed ID: 18570179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anabolic agents: recent strategies for their detection and protection from inadvertent doping.
    Geyer H; Schänzer W; Thevis M
    Br J Sports Med; 2014 May; 48(10):820-6. PubMed ID: 24632537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone and doping control.
    Saudan C; Baume N; Robinson N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i21-4. PubMed ID: 16799097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of anabolic androgenic steroids.
    Schänzer W
    Clin Chem; 1996 Jul; 42(7):1001-20. PubMed ID: 8674183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reference ranges for urinary concentrations and ratios of endogenous steroids, which can be used as markers for steroid misuse, in a Caucasian population of athletes.
    Van Renterghem P; Van Eenoo P; Geyer H; Schänzer W; Delbeke FT
    Steroids; 2010 Feb; 75(2):154-63. PubMed ID: 19962394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting the administration of endogenous anabolic androgenic steroids.
    Ayotte C
    Handb Exp Pharmacol; 2010; (195):77-98. PubMed ID: 20020361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of the misuse of steroids in doping control.
    Parr MK; Schänzer W
    J Steroid Biochem Mol Biol; 2010 Aug; 121(3-5):528-37. PubMed ID: 20036329
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.